If you would like to learn more about future focusIR related events and roundtables, please submit your details here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksArbuthnot Regulatory News (ARBB)

Share Price Information for Arbuthnot (ARBB)

Share Price is delayed by 15 minutes
Get Live Data
810.00    -5.00 (-0.61%)
Bid:
810.00
Ask:
820.00
Spread: 10.00 (1.235%)
Market Cap: £132.19m
ARBB Live PriceLast checked at - London Stock Exchange

Intraday Arbuthnot Share Chart

AGM Shareholder Consultation

26 Nov 2020 09:38

RNS Number : 6190G
Arbuthnot Banking Group PLC
26 November 2020
 

 

 

 

26 November 2020

 

 

Arbuthnot Banking Group PLC

 

Update on 2020 Annual General Meeting resolution vote

 

On 16 June 2020, Arbuthnot Banking Group PLC ("the Company" or the "Group") reported that all resolutions had been passed at its 2020 Annual General Meeting ("AGM"), held that day, but that there had been a significant minority vote against the following resolution:

• Resolution 10, authorisation for the making of political donations and incurring of political expenditure.

This resolution provided that, in the four years beginning on 17 June 2020, the individual and aggregate amount donated or expended would not exceed £250,000. In 2019, the Company made political donations of £77,000 to the Conservative Party in view of the significant adverse impact that a Labour government would have had on the Group's clients and business. The total votes received in favour of this resolution were 74.6%.

In accordance with the UK Corporate Governance Code, the Company today provides this further update. Following the AGM, the Company made contact with five institutional shareholders, comprising almost all of the votes of those which it identified as not supporting the resolution, to see whether they would like to arrange a meeting with directors as part of regular engagement and in order to understand why they voted against the resolution.

The primary reasons for not voting in favour identified as part of the consultation and the Board's response to them are set out below.

Two institutional shareholders did not take up the offer of a meeting, one of which explained that their policy on corporate governance is not to support resolutions in respect of political donations. Of the three shareholders with which the Company engaged successfully, each of the respective fund managers expressed their support for the Company, but explained that they generally follow the advice of their proxy voting advisers in respect of corporate governance matters and which, on this occasion, recommended that they voted against the resolution. One institution, whilst understanding of the reasoning behind the proposal of the resolution, indicated their own reluctance to support it due to their generally not liking companies in which they invest to make political donations. Another suggested that, if given more of an explanation as to why the resolution was being proposed, they believed that a proxy voting adviser might recommend support in which case they would likely vote in favour.

Conclusion

In summary the response to the consultation with the Company's major institutional shareholders is that, given their commitment to follow "best practice" in relation to corporate governance, they are reluctant unless there are special circumstances to go against their corporate governance/proxy voting adviser's recommendation as to how they vote.

The Board continues to believe that it is in the interests of shareholders that it has the flexibility to make political donations in accordance with the Companies Act 2016, in light of prevailing political circumstances over the next few years. Going forward it will seek to provide a more detailed explanation in relation to specific shareholder resolutions which corporate governance advisers are likely to regard as non-conforming or outside best practice. The Board is encouraged by the continued support of its major shareholders. It welcomes engagement with them and will continue to maintain communications via one-to-one meetings as appropriate.

The Directors of the Company accept responsibility for the contents of this announcement.

Enquiries:

 

Arbuthnot Banking Group 0207 012 2400

Sir Henry Angest, Chairman and Chief Executive

Andrew Salmon, Group Chief Operating Officer

James Cobb, Group Finance Director

 

Grant Thornton UK LLP (Nominated Adviser and 0207 383 5100

AQSE Corporate Advisor)

Colin Aaronson / Samantha Harrison / Seamus Fricker

 

 

Numis Securities Ltd (Joint Broker) 0207 260 1000

Stephen Westgate

 

Shore Capital Ltd (Joint Broker) 0207 408 4090

Hugh Morgan/ Daniel Bush

 

Maitland/AMO (Financial PR) 0207 379 5151

Neil Bennett / Sam Cartwright / Jonathan Cook

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
UPDGCBDBLXDDGGL
Date   Source Headline
1st Jun 20267:00 amRNSAdmission of Non-Voting Shares to Trading on AIM
20th May 20267:00 amRNSAppointment of New Non-Executive Director
19th May 20263:45 pmRNSResult of AGM
19th May 20262:34 pmRNSAnnual General Meeting 2026 & Trading Update
26th Mar 20263:37 pmRNSDirector/PDMR Shareholding
26th Mar 20267:00 amRNSAudited Final Results for the year to 31/12/2025
11th Mar 20262:34 pmRNSHolding(s) in Company
19th Feb 20267:00 amRNSPre Close Trading Update
23rd Oct 20257:00 amRNSThird Quarter 2025 Trading Update
22nd Jul 20257:00 amRNSUnaudited results for the six months to 30/06/2025
8th Jul 20257:00 amRNSAppointment of independent non-executive director
21st May 20253:40 pmRNSResult of AGM
21st May 20252:19 pmRNS2025 AGM Trading Update
27th Mar 20257:00 amRNSAudited Final Results for the year ended 31/12/24
20th Feb 20257:00 amRNSPre-Close Trading Update
25th Nov 20242:31 pmRNSDirector/PDMR Shareholding
17th Oct 20247:00 amRNSThird Quarter 2024 Trading Update
12th Aug 20248:59 amRNSChange of Registered Office
23rd Jul 20247:00 amRNSUnaudited results for the six months to 30/06/2024
2nd Jul 20249:41 amRNSAppointment of Independent Non-Executive Director
5th Jun 20243:35 pmRNSHolding(s) in Company
4th Jun 202412:02 pmRNSCompletion of Tier 2 Reg. Cap. Facility Renewal
30th May 20247:00 amRNSNotification of Special and Interim Dividends
22nd May 20243:41 pmRNSResult of AGM
22nd May 20247:00 amRNSAnnual General Meeting 2024 Trading Update
22nd Apr 20243:49 pmEQSQ&A on Arbuthnot Banking Group (ARBB) | 2023 results, strategic choices paying dividends
8th Apr 20243:50 pmEQSHardman & Co Research on Arbuthnot Banking Group (ARBB): 2023 - delivering strategy with strong profit growth
28th Mar 20247:00 amRNSAudited Final Results
21st Feb 20247:00 amRNSPre Close Trading Update
8th Feb 20241:57 pmRNSDirector/PDMR Shareholding
19th Dec 20232:06 pmRNSRenewal of Tier 2 Regulatory Capital Loan facility
5th Dec 202312:47 pmRNSDirector/PDMR Shareholding
13th Nov 20233:40 pmEQSHardman & Co Q&A on Arbuthnot Banking Group: Strategic progress and investments towards ‘Future State 2’
30th Oct 202310:34 amRNSDirector/PDMR Shareholding
26th Oct 202310:05 amRNSDirector/PDMR Shareholding
24th Oct 20233:15 pmEQSHardman & Co Research on Arbuthnot Banking Group (ARBB) Trading update: taking ABG to the next level
19th Oct 20237:00 amRNSThird Quarter 2023 Trading Update
22nd Aug 20237:00 amRNSAppointment of New Directors
4th Aug 202311:15 amEQSHardman & Co Research on Arbuthnot Banking Group (ARBB) 1H’23: steering through the interest rate wave
18th Jul 20237:00 amRNSUnaudited results for the 6 months to 30 June 2023
31st May 202312:37 pmRNSDirector/PDMR Shareholding
31st May 20237:00 amRNSTotal Voting Rights
24th May 20233:23 pmRNSAnnual General Meeting Result - 2023
24th May 20237:00 amRNSAnnual General Meeting 2023 Trading Update
5th May 20233:27 pmRNSHolding(s) in Company
5th May 20238:05 amRNSDirector/PDMR Shareholding
4th May 202311:32 amRNSResult of General Meeting and Total Voting Rights
3rd May 20231:45 pmEQSHardman & Co Q&A on Arbuthnot Banking Group (ARBB): Core and new franchises growth in profits and loans
14th Apr 20235:30 pmRNSPlacing and Subscription raising £12.0 million
6th Apr 202312:15 pmEQSHardman & Co Research on Arbuthnot Banking Group (ARBB) 2022: profits and growth in core and new franchises

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.